Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Skin Cancer01:30

Skin Cancer

4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bintrafusp alfa for patients with recurrent or metastatic olfactory neuroblastoma.

Cancer immunology, immunotherapy : CII·2026
Same author

Expansion of pathogens and restoration of human skin microbiome in CD4 T-cell lymphopenia.

The Journal of investigative dermatology·2026
Same author

Merkel cell carcinoma virus positivity ranges from 57% to 77% in the United States based on geographic region: A pooled cohort study.

Journal of the American Academy of Dermatology·2026
Same author

Acute T-cell leukemia/lymphoma presenting with leukemia cutis mimicking prurigo nodularis.

JAAD case reports·2026
Same author

Immunotherapy Significantly Improves Merkel Cell Carcinoma-Specific Survival: A Single-Cohort Propensity Score-Matched Analysis.

medRxiv : the preprint server for health sciences·2026
Same author

ATP13A2 Loss of Function-Driven Polyamine Dysregulation Induces SAM Depletion and Epigenetic Astrocyte Toxicity.

bioRxiv : the preprint server for biology·2026
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
查看所有相关文章

相关实验视频

Updated: Jun 19, 2025

Merkel Cell Polyomavirus Infection and Detection
13:45

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

9.9K

梅克尔细胞癌是什么意思

Jennifer Strong1, Patrick Hallaert1, Isaac Brownell1

  • 1Dermatology Branch, NIAMS, NIH, 10 Center Drive, 12N240C, Bethesda, MD 20892-1908, USA.

Hematology/oncology clinics of North America
|July 26, 2024
PubMed
概括
此摘要是机器生成的。

默克尔细胞癌 (MCC) 是一种罕见的皮肤癌,通过免疫疗法有效治疗. 研究正在进行中,以优化治疗持续时间,并探索耐火病例的替代方案.

关键词:
免疫治疗是一种免疫疗法.梅克尔细胞癌瘤是什么?默克尔细胞多聚马病毒神经内分泌的神经内分泌皮肤癌是一种皮肤癌.

更多相关视频

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

21.3K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.7K

相关实验视频

Last Updated: Jun 19, 2025

Merkel Cell Polyomavirus Infection and Detection
13:45

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

9.9K
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

21.3K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.7K

科学领域:

  • 在瘤学瘤学.
  • 皮肤病学 皮肤病学
  • 免疫学 免疫学 免疫学

背景情况:

  • 默克尔细胞癌 (MCC) 是一种罕见的,侵袭性的神经内分泌性皮肤癌.
  • MCC 具有较高的辐射敏感性和免疫性.
  • 免疫疗法,特别是免疫检查点抑制剂,是晚期MCC的主要治疗方法.

研究的目的:

  • 审查默克尔细胞癌的特征和治疗方法.
  • 突出MCC治疗的最新创新和积极研究的领域.
  • 讨论免疫疗法和新兴生物标志物在MCC中的作用.

主要方法:

  • 这是一篇综述性文章,综合了现有的研究和临床发现.
  • 该审查涵盖了MCC的流行病学,病理学,诊断和治疗方式.
  • 专注于免疫疗法,新辅助/辅助疗法和生物标志物研究.

主要成果:

  • 免疫检查点抑制剂在高风险MCC的新辅助或辅助环境中表现有希望.
  • 对瘤负担的新兴生物标志物对于风险分层和监测至关重要.
  • 抗PD-(L) 1治疗的最佳持续时间和耐火性MCC的二线选择需要进一步调查.

结论:

  • 免疫疗法是先进的默克尔细胞癌管理的基石.
  • 生物标志物研究和进一步的临床试验对于完善MCC治疗策略至关重要.
  • 需要继续进行研究,以解决治疗耐药性和优化长期结果.